Kathleen Melbourne Selected Research

lamivudine drug combination abacavir

9/2014	Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
3/2014	Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.
7/2012	Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.
6/2011	Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen Melbourne Research Topics

Disease

3	Inflammation (Inflammations) 10/2020 - 07/2012
2	Weight Gain 10/2021 - 12/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2014 - 06/2011
1	Nausea 01/2022
1	Fatigue 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Diarrhea 01/2022
1	Vomiting 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Insulin Resistance 01/2017
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Albuminuria 09/2014
1	Proteinuria 09/2014
1	Chronic Renal Insufficiency 03/2014

Drug/Important Bio-Agent (IBA)

6	Tenofovir (Viread)FDA Link 12/2020 - 06/2011
4	efavirenz (Sustiva)FDA Link 12/2020 - 06/2011
4	lamivudine drug combination abacavir FDA Link 09/2014 - 06/2011
4	Emtricitabine (Emtriva)FDA Link 09/2014 - 06/2011
3	abacavir (Ziagen)FDA Link 10/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2014
3	Ritonavir (Norvir)FDA Link 01/2017 - 06/2011
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2017 - 06/2011
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2020
2	IntegrasesIBA 01/2022 - 12/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	Reverse Transcriptase InhibitorsIBA 12/2020 - 09/2014
2	NucleotidesIBA 12/2020 - 09/2014
2	RacivirIBA 09/2014 - 07/2012
1	Biological FactorsIBA 01/2021
1	dolutegravirIBA 12/2020
1	tenofovir alafenamideIBA 12/2020
1	elvitegravirIBA 12/2020
1	bictegravirIBA 12/2020
1	Rilpivirine (TMC-278)IBA 12/2020
1	CobicistatIBA 12/2020
1	NucleosidesIBA 12/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Zidovudine (Retrovir)FDA LinkGeneric 12/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	NLR ProteinsIBA 10/2020
1	InflammasomesIBA 10/2020
1	LipidsIBA 01/2017
1	Phosphorus (Red Phosphorus)IBA 01/2017
1	Thymidine Monophosphate (TMP)IBA 01/2017
1	Phosphates (Orthophosphate)IBA 01/2017
1	Cystatin CIBA 03/2014
1	CreatinineIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 02/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	Cell Adhesion MoleculesIBA 02/2014
1	C-Reactive ProteinIBA 02/2014

Therapy/Procedure

4	Art Therapy 10/2021 - 09/2014
4	Therapeutics 01/2021 - 02/2014